How should I draw and administer a 110‑milligram dose of enoxaparin from a 120‑milligram/0.8‑milliliter vial?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 25, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Drawing and Administering 110 mg Enoxaparin from a 120 mg/0.8 mL Vial

To administer 110 mg from a 120 mg/0.8 mL vial, draw 0.73 mL using a standard 1 mL syringe and administer subcutaneously.

Calculation Method

  • The concentration of your vial is 150 mg/mL (120 mg ÷ 0.8 mL = 150 mg/mL) 1
  • To deliver 110 mg: divide 110 mg by 150 mg/mL = 0.73 mL 1
  • Use a standard 1 mL syringe graduated in 0.01 mL increments for accurate measurement 2

Step-by-Step Administration Protocol

Drawing the Dose

  • Remove the protective cap from the prefilled syringe or vial 1
  • Draw exactly 0.73 mL into a 1 mL syringe (this equals 110 mg) 2
  • Expel any air bubbles by tapping the syringe gently and pushing the plunger to the 0.73 mL mark 1
  • Verify the volume is precisely at 0.73 mL before proceeding 2

Subcutaneous Injection Technique

  • Select an injection site on the left or right anterolateral or posterolateral abdominal wall 1
  • Do not inject into muscle tissue—enoxaparin must be given subcutaneously 1
  • Pinch a fold of skin between thumb and forefinger 1
  • Insert the entire length of the needle at a 90-degree angle into the skin fold 1
  • Inject the full dose without aspirating 1
  • Hold the skin fold throughout the injection and for 10 seconds after withdrawal 1
  • Do not rub the injection site, as this increases bruising risk 1

Critical Safety Considerations

  • Renal function check is mandatory: if creatinine clearance is <30 mL/min, the dose must be reduced to 1 mg/kg once daily instead of twice daily 3, 1
  • For patients ≥75 years receiving this dose for acute coronary syndrome with fibrinolysis, the maximum dose should not exceed 75 mg per injection 3, 1
  • Never switch between enoxaparin and unfractionated heparin once treatment is initiated, as this substantially increases bleeding risk 4, 3
  • If the patient weighs <50 kg, consider anti-Xa monitoring due to increased bleeding risk with standard weight-based dosing 1

Common Pitfalls to Avoid

  • Do not round to 0.7 mL or 0.75 mL—use the precise 0.73 mL calculation to avoid under- or over-dosing 2
  • Avoid intramuscular injection, which can cause hematoma formation 1
  • Do not administer within 10–12 hours of neuraxial anesthesia or epidural catheter removal 3, 1
  • Never use insulin syringes for doses requiring decimal precision in adults—use a standard 1 mL syringe with 0.01 mL graduations 2

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.